Copied
 
 
2022, DKK
28.11.2023
Bruttoresultat

29.872'

Primær drift

-1.489'

Årets resultat

-1.092'

Aktiver

42.449'

Kortfristede aktiver

34.320'

Egenkapital

29.924'

Afkastningsgrad

-4 %

Soliditetsgrad

70 %

Likviditetsgrad

420 %

Resultat
28.11.2023
Årsrapport
2022
28.11.2023
2021
06.12.2022
2020
06.12.2021
2019
09.12.2020
2018
05.12.2019
2017
03.12.2018
2016
30.11.2017
2015
30.11.2016
Nettoomsætning
Bruttoresultat29.872.20218.937.90324.389.36215.279.63911.948.09512.135.12012.621.22710.163.371
Resultat af primær drift-1.488.884-10.509.436698.030-2.260.174-2.405.4762.318.4304.379.3023.560.169
Indtægter af kapitalandele (tilknyttede og associerede) 00000000
Finansielle indtægter739.7902.191.588413.325659.005557.144485.2391.094.457878.886
Finansieringsomkostninger00000000
Andre finansielle omkostninger-1.033.404-260.316-1.012.054-710.224-40.361-1.772.749-1.270.537-1.207.195
Resultat før skat-1.367.650-9.186.65548.727-2.203.700-2.497.0291.273.372-78.175-1.100.276
Resultat-1.092.079-6.768.594754.454-1.671.408-2.083.5641.223.5603.867.565-1.100.276
Forslag til udbytte00000000
Aktiver
28.11.2023
Årsrapport
2022
28.11.2023
2021
06.12.2022
2020
06.12.2021
2019
09.12.2020
2018
05.12.2019
2017
03.12.2018
2016
30.11.2017
2015
30.11.2016
Kortfristede varebeholdninger8.761.3267.735.4227.805.6697.673.8986.917.5056.852.9706.714.0565.314.000
Kortfristede tilgodehavender fra salg og tjenesteydelser 19.918.75720.920.58816.328.51424.472.77112.450.36613.412.96711.849.8225.594.006
Likvider5.640.3665.874.56415.265.7347.804.3707.331.6457.361.4766.766.445406.023
Kortfristede aktiver34.320.44934.530.57439.399.91739.951.03926.699.51627.627.41325.330.32311.314.029
Immaterielle aktiver og goodwill3.434.0721.078.6611.012.87300000
Finansielle anlægsaktiver522.060473.270461.293480.406460.560260.108241.190349.616
Materielle aktiver4.172.7954.977.7685.966.4635.531.9851.263.5531.130.651635.340122.205
Langfristede aktiver8.128.9276.529.6997.440.6296.012.3911.724.1131.390.759876.530471.821
Aktiver42.449.37641.060.27346.840.54645.963.43028.423.62929.018.17226.206.85311.785.850
Aktiver
28.11.2023
Passiver
28.11.2023
Årsrapport
2022
28.11.2023
2021
06.12.2022
2020
06.12.2021
2019
09.12.2020
2018
05.12.2019
2017
03.12.2018
2016
30.11.2017
2015
30.11.2016
Forslag til udbytte00000000
Egenkapital29.924.13629.375.65334.451.42333.696.96912.853.03014.936.59413.713.0341.464.151
Hensatte forpligtelser00000000
Langfristet gæld til banker00000000
Anden langfristet gæld0000000
Leverandører af varer og tjenesteydelser2.840.8993.052.2972.529.9102.643.7642.183.6742.379.0761.984.0081.015.768
Kortfristede forpligtelser8.165.3707.251.3167.765.5649.016.19615.570.59914.081.57812.493.81910.321.699
Gældsforpligtelser12.525.24011.684.62012.389.12312.266.46115.570.59914.081.57812.493.81910.321.699
Forpligtelser12.525.24011.684.62012.389.12312.266.46115.570.59914.081.57812.493.81910.321.699
Passiver42.449.37641.060.27346.840.54645.963.43028.423.62929.018.17226.206.85311.785.850
Passiver
28.11.2023
Nøgletal
28.11.2023
Årsrapport
2022
28.11.2023
2021
06.12.2022
2020
06.12.2021
2019
09.12.2020
2018
05.12.2019
2017
03.12.2018
2016
30.11.2017
2015
30.11.2016
Afkastningsgrad -3,5 %-25,6 %1,5 %-4,9 %-8,5 %8,0 %16,7 %30,2 %
Dækningsgrad Na.Na.Na.Na.Na.Na.Na.Na.
Resultatgrad Na.Na.Na.Na.Na.Na.Na.Na.
Varelagerets omsætningshastighed Na.Na.Na.Na.Na.Na.Na.Na.
Egenkapitals-forretning -3,6 %-23,0 %2,2 %-5,0 %-16,2 %8,2 %28,2 %-75,1 %
Payout-ratio Na.Na.Na.Na.Na.Na.Na.Na.
Gældsdæknings-nøgletal Na.Na.Na.Na.Na.Na.Na.Na.
Soliditestgrad 70,5 %71,5 %73,6 %73,3 %45,2 %51,5 %52,3 %12,4 %
Likviditetsgrad 420,3 %476,2 %507,4 %443,1 %171,5 %196,2 %202,7 %109,6 %
Resultat
28.11.2023
Gæld
28.11.2023
Årsrapport
28.11.2023
Nyeste:01.07.2022- 30.06.2023(offentliggjort: 28.11.2023)
Information om virksomhedens regnskabsklasse:This annual report has been presented in accordance with the provisions of the Danish Financial Statements Act governing reporting class B enterprises with addition of a few provisions for reporting class C. The accounting policies applied to these financial statements are consistent with those applied last year.
Beretning
28.11.2023
Dato for ledelsens godkendelse af årsrapporten:2023-11-17
Beskrivelse af usikkerhed ved indregning eller måling:Uncertainty relating to recognition and measurementThe value of the capitalized development projects depends on the companys ability to finalize the development projects in progress and the companys ablility to attract enough customers to achieve a return of the invested capital. The assessment of the management is that this will happen within a manageable timeline.
Statement by Management on the annual report
Identifikation af den godkendte årsrapport:The Board of Directors and the Executive Board have today considered and approved the annual report of Immudex ApS for the financial year 01. 07. 2022 - 30. 06. 2023.
Management's review
Beskrivelse af virksomhedens væsentligste aktiviteter:Primary activitiesThe main activities of Immudex is to provide MHC Dextramer® reagents for improved cellular immune monitoring to be used in research, clinical development and patient monitoring.